Medicine
Aranesp 40 mcg/0.4 mL injection
Aranesp 40 mcg/0.4 mL injection is a prescription medicine containing Darbepoetin alfa for intravenous, subcutaneous use, marketed by Amgen, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store at 36°F to 46°F (2°C to 8°C). Do not freeze. Do not shake. Protect from…
Key facts
- Active ingredient (INN)
- Darbepoetin alfa
- Brand
- Aranesp
- Strength
- 40 mcg/0.4 mL
- Dosage form
- Injection
- Route
- Intravenous, subcutaneous
- Packs
- 1 blister pack of 0.4 mL
- Marketing authorisation holder
- Amgen
- Manufacturer
- Amgen
- Origin register
- US FDA, United States
- Storage
- Store at 36°F to 46°F (2°C to 8°C). Do not freeze. Do not shake. Protect from light, store Aranesp in the carton until use.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- B03XA02 Darbepoetin alfa
- HS code (indicative)
- 3002.15Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 14 August 2006
- Identifiers
- RxCUI 349273, 349274, 349275 +7DailyMed set ID 0fd36cb9-c4f6-4167-93c9-8530865db3f9NDC 55513-021Application BLA103951
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 blister pack in 1 package / 4 syringe in 1 blister pack / .4 mL in 1 syringe | 55513-021-04 | Amgen | 14 August 2006 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Darbepoetin alfa
Clinical summary
Darbepoetin alfa is an erythropoiesis-stimulating agent indicated for the treatment of anemia due to chronic Kidney Disease (CKD) in patients on dialysis and patients not on dialysis, among other approved uses. MedsAcross supplies Darbepoetin alfa for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Darbepoetin alfaFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- ARANESP prescribing information (Amgen) · U.S. National Library of Medicine, DailyMed
- Aranesp: European public assessment report (EPAR) · European Medicines Agency
Need Aranesp 40 mcg/0.4 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.